Evidence map›Paper›PMID 32162654›Full record

ArticleJournal of molecular cell biology2020

Cyclophilins A and B oppositely regulate renal tubular epithelial cell phenotype.

Eduard Sarró, Mónica Durán, Ana Rico, Diana Bou-Teen, Vanesa Fernández-Majada, Anthony J Croatt, Karl A Nath, Maria Teresa Salcedo, Justin H Gundelach, Daniel Batlle and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of molecular cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Eduard SarróRenal Physiopathology Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Mónica DuránRenal Physiopathology Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Ana RicoRenal Physiopathology Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Diana Bou-TeenCardiovascular Diseases Group, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Vanesa Fernández-MajadaBiomimetic Systems for Cell Engineering Laboratory, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
Anthony J CroattDivision of Nephrology and Hypertension and Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Karl A NathDivision of Nephrology and Hypertension and Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Maria Teresa SalcedoDepartment of Pathology, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
Justin H GundelachDepartment of Pediatric and Adolescent Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Daniel BatlleDivision of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Richard J BramDepartment of Pediatric and Adolescent Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Anna MeseguerRenal Physiopathology Group, CIBBIM-Nanomedicine, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.
Mayo Clinic · USVall d'Hebron Institut de Recerca · ESInstitute for Bioengineering of Catalonia · ESNorthwestern University · USUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

Renal Injury and Adaptation to Heme ProteinsR37DK047060 · NIDDK · MAYO CLINIC ROCHESTER · PI NATH, KARL A. · 2002 to 2011
$3.6M
RENAL INJURY AND ADAPTATION TO HEME PROTEINSR01DK047060 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NATH, KARL A. · 1993 to 2018
$2.2M
NIDDK NIH HHS R01 DK047060NIDDK NIH HHS R37 DK047060
6 · The paper itself

Abstract

Restoration of kidney tubular epithelium following sublethal injury sequentially involves partial epithelial-mesenchymal transition (pEMT), proliferation, and further redifferentiation into specialized tubule epithelial cells (TECs). Because the immunosuppressant cyclosporine-A produces pEMT in TECs and inhibits the peptidyl-prolyl isomerase (PPIase) activity of cyclophilin (Cyp) proteins, we hypothesized that cyclophilins could regulate TEC phenotype. Here we demonstrate that in cultured TECs, CypA silencing triggers loss of epithelial features and enhances transforming growth factor β (TGFβ)-induced EMT in association with upregulation of epithelial repressors Slug and Snail. This pro-epithelial action of CypA relies on its PPIase activity. By contrast, CypB emerges as an epithelial repressor, because CypB silencing promotes epithelial differentiation, prevents TGFβ-induced EMT, and induces tubular structures in 3D cultures. In addition, in the kidneys of CypB knockout mice subjected to unilateral ureteral obstruction, inflammatory and pro-fibrotic events were attenuated. CypB silencing/knockout leads to Slug, but not Snail, downregulation. CypB support of Slug expression depends on its endoplasmic reticulum location, where it interacts with calreticulin, a calcium-buffering chaperone related to Slug expression. As CypB silencing reduces ionomycin-induced calcium release and Slug upregulation, we suggest that Slug expression may rely on CypB modulation of calreticulin-dependent calcium signaling. In conclusion, this work uncovers new roles for CypA and CypB in modulating TEC plasticity and identifies CypB as a druggable target potentially relevant in promoting kidney repair.

Indexed as

AnimalsBasiginCalciumCell LineCyclophilinsEndoplasmic ReticulumEpithelial CellsFibrosisGene SilencingHumansInflammationIonomycinKidney TubulesMicePhenotypeProtein TransportBasiginCalciumCyclophilinsIonomycinSmad ProteinsSnail Family Transcription FactorsThapsigarginTransforming Growth Factor betacyclophilinsepithelial phenotypefibrosisSlugTGFβUUO

Identifiers

PMID32162654
PMCPMC7493029
OpenAlexW3011393608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.